Back to AUPH
MARSHALL WACE, LLP AUPH Position History
Aurinia Pharmaceuticals Inc. • Healthcare
Quarters held
9
Latest value
$33.3M
Q2 2026
Peak value
$33.3M
First seen
Q3 2023
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2023 | $190K |
| Q2 2025 | $915K |
| Q3 2025 | $16.4M |
| Q4 2025 | $66K |
| Q4 2025 | $25.1M |
| Q1 2026 | $851K |
| Q1 2026 | $26.9M |
| Q2 2026 | $1.4M |
| Q2 2026 | $33.3M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $33.3M | 1.96M | — | — |
| Q2 2026 | $1.4M | 80.1K | — | — |
| Q1 2026 | $26.9M | 1.82M | — | — |
| Q1 2026 | $851K | 57.4K | — | — |
| Q4 2025 | $25.1M | 1.57M | — | — |
| Q4 2025 | $66K | 4.1K | — | — |
| Q3 2025 | $16.4M | 1.48M | — | — |
| Q2 2025 | $915K | 108.1K | — | — |
| Q3 2023 | $190K | 24.5K | — | — |